rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
19
|
pubmed:dateCreated |
1998-4-24
|
pubmed:abstractText |
The aim of this study was to evaluate the relationship between plasma elimination of lidocaine and monoethylglycinexylidide (MEGX) formation, which is considered to be a quantitative liver function test.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0172-6390
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
154-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9496506-Adolescent,
pubmed-meshheading:9496506-Adult,
pubmed-meshheading:9496506-Chronic Disease,
pubmed-meshheading:9496506-Female,
pubmed-meshheading:9496506-Half-Life,
pubmed-meshheading:9496506-Hepatitis, Chronic,
pubmed-meshheading:9496506-Humans,
pubmed-meshheading:9496506-Lidocaine,
pubmed-meshheading:9496506-Liver,
pubmed-meshheading:9496506-Liver Cirrhosis,
pubmed-meshheading:9496506-Liver Function Tests,
pubmed-meshheading:9496506-Male,
pubmed-meshheading:9496506-Middle Aged
|
pubmed:articleTitle |
Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
|
pubmed:affiliation |
Department of Internal Medicine, University of Genoa, Italy.
|
pubmed:publicationType |
Journal Article
|